ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC34309-1mg |
|
— |
Cycloguanil D6 (Chlorguanide triazine D6)
|
0 | C11H8D6ClN5 | |
GC34308-1mg |
|
— |
Cycloguanil D6 Nitrate (Chlorguanide triazine D6 Nitrate)
|
0 | C11H9D6ClN6O3 | |
GC34307-100mg |
|
— |
IFN alpha-IFNAR-IN-1 hydrochloride (IFN-alpha and IFNAR interaction inhibitor)
|
0 | C18H18ClNS | |
GC34307-50mg |
|
— |
IFN alpha-IFNAR-IN-1 hydrochloride (IFN-alpha and IFNAR interaction inhibitor)
|
0 | C18H18ClNS | |
GC34307-10mg |
|
— |
IFN alpha-IFNAR-IN-1 hydrochloride (IFN-alpha and IFNAR interaction inhibitor)
|
0 | C18H18ClNS | |
GC34307-5mg |
|
— |
IFN alpha-IFNAR-IN-1 hydrochloride (IFN-alpha and IFNAR interaction inhibitor)
|
0 | C18H18ClNS | |
GC34307-10mM(1mLinDMSO) |
|
— |
IFN alpha-IFNAR-IN-1 hydrochloride (IFN-alpha and IFNAR interaction inhibitor)
|
0 | C18H18ClNS | |
GC34306-10mg |
|
— |
Talabostat isomer mesylate
|
0 | C10H23BN2O6S | |
GC34306-5mg |
|
— |
Talabostat isomer mesylate
|
0 | C10H23BN2O6S | |
GC34306-10mM(1mLinDMSO) |
|
— |
Talabostat isomer mesylate
|
0 | C10H23BN2O6S | |
GC34305-10mg |
|
— |
Bendamustine D4 (SDX-105 D4)
|
0 | C16H17D4Cl2N3O2 | |
GC34305-5mg |
|
— |
Bendamustine D4 (SDX-105 D4)
|
0 | C16H17D4Cl2N3O2 | |
GC34305-1mg |
|
— |
Bendamustine D4 (SDX-105 D4)
|
0 | C16H17D4Cl2N3O2 | |
GC34304-100mg |
|
— |
Befiradol hydrochloride (NLX-112 (hydrochloride))
|
0 | C20H23Cl2F2N3O | |
GC34304-50mg |
|
— |
Befiradol hydrochloride (NLX-112 (hydrochloride))
|
0 | C20H23Cl2F2N3O | |
GC34304-25mg |
|
— |
Befiradol hydrochloride (NLX-112 (hydrochloride))
|
0 | C20H23Cl2F2N3O | |
GC34304-10mg |
|
— |
Befiradol hydrochloride (NLX-112 (hydrochloride))
|
0 | C20H23Cl2F2N3O | |
GC34304-5mg |
|
— |
Befiradol hydrochloride (NLX-112 (hydrochloride))
|
0 | C20H23Cl2F2N3O | |
GC34304-10mM(1mLinDMSO) |
|
— |
Befiradol hydrochloride (NLX-112 (hydrochloride))
|
0 | C20H23Cl2F2N3O | |
GC34303-50mg |
|
— |
Taltobulin hydrochloride (HTI-286 hydrochloride)
|
0 | C27H44ClN3O4 | |